drugset / Trial / NCT06670170

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

NCT06670170

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

The primary purpose of this study is to measure and compare the amount of study drug in your blood after a single dose of two formulations of study drug.

Timeline

Start
2024-11-05
Primary completion
2024-12-24
Completion
2025-01-17

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-07976016 Unknown Oral

Indications

No indication recorded.